|
|
|
|
|
Diagnostic Molecular Imaging for Prostate Cancer in the United States: A Focus on Lesion Localization and Distribution Using 18F-DCFPyL PET/CT at Biochemical Recurrence
|
|
Andrei H. Iagaru, MD, FACNM
|
| Andrei Iagaru joins Phillip Koo, Alicia Morgans, and Neal Shore, presenting a lecture and discussion on the significant progress in the field of molecular imaging and theragnostics for prostate cancer.
|
|
|
|
|
|
|
|
|
|
|
|
|
Implications of PSMA PET Imaging for Prostate Cancer
|
|
A. Oliver Sartor, MD
|
| In this educational lecture, Oliver Sartor presents on evaluating treatment assessments and changes, metastasis directed therapy for oligometastatic disease, and treatment decisions based upon scans for early disease, specifically, look at the OSPREY trial.
|
|
|
|
|
|
|
|
|
|
|
|
|
The Biology of Prostate Cancer Metastasis and What PSMA Imaging Is Teaching Us: Presentation and Discussion
|
|
Kenneth Pienta, MD
|
| In this educational lecture, Kenneth Pienta presents on the biology of prostate cancer metastasis and what PSMA imaging is teaching us, a topic changing the way urologists and medical oncologists approach the treatment of prostate cancer. Drs. Alicia Morgans and Michael Cookson join Dr. Pienta for a closing discussion on the biology of PSMA and PET imaging.
|
|
|
|
|
|
|
|
|
|
|
|
|
OSPREY and CONDOR Trials - Evaluating F-18 DCFPyL PSMA Imaging for Prostate Cancer
|
|
Michael Morris, MD
|
| In this educational lecture, Michael Morris presents on PET PSMA imaging in prostate cancer, and a specific talk on PyL PET imaging. He highlights the OSPREY and the CONDOR studies detailing PSMA imaging and specifically the relationship to 18F PSMA imaging with the compound DCFPyL.
|
|
|
|
|
|
|
|
|
|
|
|
|
Applying Artificial Intelligence (AI) to PSMA-targeted PET Imaging Agent 18F-DCFPyL in Prostate Cancer
|
|
Matthew Rettig, MD
|
| In this program lecture, Matthew Rettig discusses the application of artificial intelligence or AI to PSMA PET-CT imaging in prostate cancer. Following his presentation, Dr. Rettig is joined by Phillip Koo, Alicia Morgans, and Neal Shore for a 360-degree perspective on AI in prostate cancer.
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
